| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $234,921,552 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R33MH126094 | Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness | 000 | 4 | NIH | 3/5/2026 | $742,014 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R33MH136135 | Mindfulness Engaged Neurostimulation for Depression (MEND) | 000 | 3 | NIH | 4/28/2026 | $889,216 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R25EB038215 | Progressive Clinical Team-Based Design and Skill-Building Across All Undergraduate Levels Assisted by Clinical Digital Twins | 000 | 1 | NIH | 3/17/2026 | $21,600 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R25HL145817 | UCSD Future Faculty of Cardiovascular Sciences (FOCUS) | 000 | 8 | NIH | 3/20/2026 | $342,360 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R25MH108389 | Sustained Training in Aging and HIV Research (STAHR) | 000 | 9 | NIH | 3/23/2026 | $209,974 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | T32DA023356 | Training Program in Substance Use, HIV and Related Infections | 000 | 20 | NIH | 5/13/2026 | $221,249 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | T32DK007044 | Experimental Endocrinology and Metabolism | 001 | 45 | NIH | 5/14/2026 | $194,121 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | T32GM146648 | Chemistry-Biology Interfaces at UCSD | 000 | 5 | NIH | 5/14/2026 | $147,104 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | T32GM145427 | UC San Diego Genetics Training Program | 000 | 5 | NIH | 4/28/2026 | $457,849 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | RM1DA066307 | Brain-Focused Research on Antiretrovirals and Methamphetamine (Brain-FRAMe) | 000 | 1 | NIH | 5/8/2026 | $2,475,711 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | RF1MH134175 | Optimization of the 5-choice continuous performance test to reveal a parietal-anterior cingulate-claustrum circuit underlying cognitive control and attention | 000 | 4 | NIH | 4/14/2026 | $790,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R61HL175687 | Cobinamide as a disease-modifying treatment for Marfan Syndrome: optimizaation of absorption | 000 | 2 | NIH | 5/14/2026 | $393,883 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM161808 | Functions of Kinetochore Machinery | 000 | 1 | NIH | 3/12/2026 | $479,738 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM162633 | Unveiling Hidden Cellular Architecture: Mapping the intracellular Protein Organization Landscape (iPOL) to define cell states and types | 000 | 1 | NIH | 4/1/2026 | $370,550 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37DA063274 | Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening | 001 | 2 | NIH | 5/4/2026 | $738,101 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37NS076896 | Mechanisms of Prion Spread and Neuronal Toxicity | 001 | 14 | NIH | 4/28/2026 | $59,947 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37NS076896 | Mechanisms of Prion Spread and Neuronal Toxicity | 000 | 14 | NIH | 1/16/2026 | $539,519 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37NS120496 | Structural mechanisms of nicotinic acetylcholine receptors in health and disease | 000 | 7 | NIH | 2/6/2026 | $897,651 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37MH132924 | Testing the accuracy of eye tracking as a screening tool for ASD in the general population | 001 | 4 | NIH | 4/20/2026 | $1,546,507 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35NS116810 | Determining Fundamental Properties of Neurotransmitter Switching in Adult Mammals | 000 | 7 | NIH | 5/13/2026 | $710,268 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35NS127314 | Molecular genetics of axon and synapse development and maintenance | 000 | 5 | NIH | 3/23/2026 | $862,680 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37AI052453 | Cathelicidin in Skin Immunity | 000 | 23 | NIH | 1/15/2026 | $602,803 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R37CA249659 | Advanced diffusion MRI for evaluating early response to radiation treatment in cervical cancer | 000 | 6 | NIH | 3/26/2026 | $648,284 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM141706 | High Resolution Structure Determination of Non-Coding RNAs to Reveal Functional Mechanisms | 000 | 6 | NIH | 4/22/2026 | $566,034 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | R35GM139641 | Action of Lipolytic Enzymes | 002 | 6 | NIH | 5/8/2026 | $449,249 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U2CDK136780 | The San Diego Regional Network Award for Kidney, Urologic, and Hematologic Research Training | 001 | 3 | NIH | 5/15/2026 | $225,773 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U24AA014815 | FASD Diagnostic Telemedicine Resource | 001 | 23 | NIH | 5/6/2026 | $348,448 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01NS139877 | Optimization of Transparent Microelectrode Arrays for Large-scale Multimodal Monitoring of Neural Activity | 000 | 2 | NIH | 1/19/2026 | $1,221,187 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA056006 | Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV | 000 | 5 | NIH | 4/20/2026 | $1,599,188 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA044451 | Use of Next-Gen Sequencing to Identify Genetic Variants that Influence compulsive Oxycodone Intake in Outbred Rats | 000 | 10 | NIH | 2/20/2026 | $929,874 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA041089 | 5/21 ABCD-USA Consortium: Research Project Site at UC San Diego | 000 | 12 | NIH | 4/9/2026 | $1,026,085 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA041089 | 5/21 ABCD-USA Consortium: Research Project Site at UC San Diego | 000 | 12 | NIH | 4/9/2026 | $1,000,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA058402 | Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates | 000 | 4 | NIH | 2/19/2026 | $2,463,772 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DA063078 | A binational cohort of the intersection between substance use, HIV, and associated comorbidities among people who inject drugs in San Diego, CA | 000 | 2 | NIH | 4/24/2026 | $2,454,789 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01DK135121 | Using technology to define and mitigate risk of impaired awareness of hypoglycemia in patients with type 1 diabetes | 000 | 4 | NIH | 3/5/2026 | $879,491 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | T35EY033704 | Short-Term Research training In Vision and Eye health (STRIVE) | 001 | 5 | NIH | 3/30/2026 | $20,739 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01CA278470 | National Succinate Dehydrogenase-deficient GIST Translational Research and Clinical Trial Consortium | 000 | 3 | NIH | 3/5/2026 | $636,527 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U01AA014835 | Whole Body Effects of PAE Across the Life Span: Early Markers of & Clinical Interventions for Children and Adolescents in Ukraine | 001 | 23 | NIH | 5/19/2026 | $580,092 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | T32HD007203 | Training in Reproductive Sciences | 000 | 44 | NIH | 4/23/2026 | $233,296 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | NUR3DD000101 | Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) in San Diego County | 00 | 4 | CDC | 1/5/2026 | $449,971 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | NU58DP007328 | Asian Smokers' Quitline | 00 | 4 | CDC | 5/7/2026 | $900,000 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069432 | UCSD Collaborative Clinical Trials Unit | 003 | 20 | NIH | 4/20/2026 | $353,594 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069432 | UCSD Collaborative Clinical Trials Unit | 002 | 20 | NIH | 4/17/2026 | $1,601,524 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069432 | UCSD Collaborative Clinical Trials Unit | 001 | 20 | NIH | 1/8/2026 | $621,574 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069432 | UCSD Collaborative Clinical Trials Unit | 000 | 20 | NIH | 1/7/2026 | $1,664,282 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069536 | CURE CTU | 001 | 20 | NIH | 4/28/2026 | $713,154 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1AI069536 | CURE CTU | 000 | 20 | NIH | 12/22/2025 | $674,268 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | UM1TR005449 | CTSA UM1 Program at University of California San Diego Altman Clinical and Translational Research Institute | 000 | 2 | NIH | 4/30/2026 | $10,295,345 |
| | 2026 | 2026 | UNIVERSITY OF CALIFORNIA, SAN DIEGO | 9500 GILMAN DR | LA JOLLA | CA | 92093-0021 | SAN DIEGO | USA | U24DK138512 | An interactive resource to generate and provide integrated knowledge of the human pancreas | 000 | 3 | NIH | 1/8/2026 | $1,960,275 |
|
